Eastern Bank’s Inhibrx INBX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-5
Closed -$474 – 1125
2026
Q2
$474 Buy
+5
New +$501 ﹤0.01% 1013

Other funds holding INBX

Eastern Bank's INBX Position: Q3 2026 in Review

Eastern Bank sold out of Inhibrx (INBX) in Q3 2026, closing a stake of 5 shares — an estimated $474 sold.

Eastern Bank first reported a position in INBX in Q2 2026 and held it in 1 quarter. The position peaked at $474 in Q2 2026. 173 funds tracked by Wall St. Rank hold INBX as of Q3 2026.

  • Eastern Bank reported no remaining Inhibrx position as of Q3 2026 after selling out during the quarter.
  • Eastern Bank sold 5 Inhibrx shares in Q3 2026, an estimated $474.
  • Eastern Bank first reported a position in Inhibrx in Q2 2026 and held it in 1 quarter.
  • Eastern Bank's Inhibrx position peaked at $474 in Q2 2026.
  • 173 funds tracked by Wall St. Rank held Inhibrx as of Q3 2026.

Based on Eastern Bank's 13F filing for Q3 2026, filed 5 Oct 2026.